Nicholas C DeVito

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Heat Shock Protein

Top Venues

Science immunology

Science translational medicine

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael P Plebanek, Yue Xue, Y-Van Nguyen, Nicholas C DeVito, Xueying Wang, Alisha Holtzhausen, Georgia M Beasley, Balamayooran Theivanthiran, Brent A Hanks
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Science immunology 9 (95) (2024)
Michael P Plebanek, Yue Xue, Y-Van Nguyen, Nicholas C DeVito, Xueying Wang, Alisha Holtzhausen, Georgia M Beasley, Balamayooran Theivanthiran, Brent A Hanks
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Science immunology 9 (95) (2024)
Nicholas C DeVito, Y-Van Nguyen, Michael Sturdivant, Michael P Plebanek, Kaylee Howell, Nagendra Yarla, Vaibhav Jain, Michael Aksu, Georgia M Beasley, Balamayooran Theivanthiran, Brent A Hanks
Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling. bioRxiv : the preprint server for biology (2024)
Balamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, Y-Van Nguyen, Linda Cao, Michelle Ferreira, Alisha Holtzhausen, Rami Nayef Al-Rohil, April K S Salama, Georgia M Beasley, Michael P Plebanek, Nicholas C DeVito, Brent A Hanks
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy. Science translational medicine 14 (672) (2022)
Balamayooran Theivanthiran, Tarek Haykal, Linda Cao, Alisha Holtzhausen, Michael Plebanek, Nicholas C DeVito, Brent A Hanks
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis. Cancers 13 (19) (2021)